Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 6
1  |  2  |  3  |  4  |  5  |  6

Scientific Advancements
Friday, March 15, 2019   (0 Comments - view/add)
Oragenics, Inc. Announces Enrollment of 60th Patient in Clinical Trial »
Oragenics, Inc. Announces Enrollment of 60 th Patient in Clinical Trial   March 15, 2019 04:17 PM East...
Monday, March 11, 2019   (0 Comments - view/add)
Espero BioPharma Announces Tecarfarin Receives FDA Orphan Drug Designation for Patients with End Sta »
Espero BioPharma Announces Tecarfarin Receives FDA Orphan Drug Designation for Patients with End Stage Renal Disease and A...
Tuesday, February 26, 2019   (0 Comments - view/add)
U.S. FDA Grants Market Clearance to Sensus Healthcare's New Sculptura™ Radiation Oncology System »
U.S. FDA Grants Market Clearance to Sensus Healthcare's New Sculptura™ Radiation Oncology System A Single Treatment dur...
Tuesday, February 26, 2019   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the »
Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the Treatment of Lambert-E...
Monday, February 18, 2019   (0 Comments - view/add)
Research finds ethnoracial differences in Alzheimer’s disease »
Research finds ethnoracial differences in Alzheimer’s disease Feb. 18, 2019   A study led by Mayo r...
Friday, February 8, 2019   (0 Comments - view/add)
Scripps Florida scientists' bold strategy could help breast cancer patients »
Scripps Florida scientists' bold strategy could help breast cancer patients   By Marcia Heroux Pounds...
Thursday, February 7, 2019   (0 Comments - view/add)
CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Pati »
CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick...
Monday, January 28, 2019   (0 Comments - view/add)
Oragenics, Inc. Receives Further Validation for Lantibiotic Compound OG716 »
January 28, 2018   Oragenics, Inc. Receives Further Validation for Lantibiotic Compound OG716 &nbs...
Thursday, January 24, 2019   (0 Comments - view/add)
Espero BioPharma Provides Update on the Development of Tecarfarin
for the Treatment of Mechanical He »
Espero BioPharma Provides Update on the Development of Tecarfarin for the Treatment of Mechanical Heart Valve Patients in...
Thursday, January 17, 2019   (0 Comments - view/add)
Lakewood-Amedex Prepares To Launch A Phase 2 cDFU Clinical Trial for Its Nu-3 Antimicrobial In The B »
Lakewood-Amedex Prepares To Launch A Phase 2 cDFU Clinical Trial for Its Nu-3 Antimicrobial In The Bahamas  ...
Thursday, January 17, 2019   (0 Comments - view/add)
Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination »
Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug De...
Wednesday, January 16, 2019   (0 Comments - view/add)
AxoGen Announces RECON® Study Update »
AxoGen Announces RECON® Study Update Study Supports Company’s Planned Biologic License Application (BLA) for Avance® N...
Monday, January 7, 2019   (0 Comments - view/add)
KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ® (4.08 mg benzhydroco »
KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ® (4.08 mg benzhydrocodone/325 mg APAP and 8...
Friday, January 4, 2019   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Publication of Clinical Data from the Investigator-Sponsored Phas »
Catalyst Pharmaceuticals Announces Publication of Clinical Data from the Investigator-Sponsored Phase IIb Study Evaluating...
Wednesday, December 19, 2018   (0 Comments - view/add)
Mice no more? Hesperos’ Multi-organ “Human-on-a-Chip” System Found Effective for Long-Term Toxicolo »
Mice no more? Hesperos’ Multi-organ “Human-on-a-Chip” System Found Effective for Long-Term Toxicology Testing...
Friday, November 30, 2018   (0 Comments - view/add)
QIAGEN and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion D »
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly a...
Thursday, November 29, 2018   (0 Comments - view/add)
FDA Approves Firdapse® (Amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) »
FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)   -...
Tuesday, November 20, 2018   (0 Comments - view/add)
LECOM Seeking Patients for an Innovative Research Study into Musculoskeletal Health »
LECOM Seeking Patients for an Innovative Research Study into Musculoskeletal Health Erie, PA. –November...
Monday, November 19, 2018   (0 Comments - view/add)
Rocket delivers cell samples to ISS to study effects of microgravity on muscles »
Rocket delivers cell samples to ISS to study effects of microgravity on muscles   Muscle cells from Flori...
Thursday, November 15, 2018   (0 Comments - view/add)
Oragenics, Inc. Receives Clearance to Enroll Patients in Germany and the United Kingdom into Its Pha »
Oragenics, Inc. Receives Clearance to Enroll Patients in Germany and the United Kingdom into Its Phase 2 Clinical Trial of...
Tuesday, November 13, 2018   (0 Comments - view/add)
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use D »
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use Disorder Novem...
Tuesday, October 30, 2018   (0 Comments - view/add)
FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format »
FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format RPS D...
Monday, October 29, 2018   (0 Comments - view/add)
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation »
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation RMAT Designation reinforces c...
Monday, October 29, 2018   (0 Comments - view/add)
TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA™ (Estradiol and Progesterone) Capsules for »
TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA™ (Estradiol and Progesterone) Capsules for the Treatment of Mode...
Tuesday, October 23, 2018   (0 Comments - view/add)
KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multipl »
KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multiple Indications &n...
Wednesday, October 17, 2018   (0 Comments - view/add)
Oragenics, Inc. Receives Clearance to Enroll Patients in Belgium into Its Phase 2 Clinical Trial of »
Oragenics, Inc. Receives Clearance to Enroll Patients in Belgium into Its Phase 2 Clinical Trial of AG013 for Oral Mucosit...
Tuesday, October 16, 2018   (0 Comments - view/add)
Medtronic launches workflow system to help wean patients off oral opioids »
Medtronic launches workflow system to help wean patients off oral opioids Sarah Faulkner October 16, 201...
Monday, October 15, 2018   (0 Comments - view/add)
CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™ »
CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™ Company expects to provide...
Thursday, October 11, 2018   (0 Comments - view/add)
ADMA Biologics Provides Regulatory Update for BIVIGAM® »
ADMA Biologics Provides Regulatory Update for BIVIGAM®     RAMSEY, N.J. and BOCA RATON, Fla., Oct. 11,...
Friday, October 5, 2018   (0 Comments - view/add)
CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo »
CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Nie...
Wednesday, October 3, 2018   (0 Comments - view/add)
CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ adminis »
CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ administered intravenously in...
Wednesday, October 3, 2018   (0 Comments - view/add)
MPFI Scientist Wins $6.8 Million NIH Grant For Breakthrough Technique to Map Neuromodulators Within »
For Immediate Release Media Contact: Katie Edwards, Head of Public Communications Katie.edwards@mpfi.org...
Tuesday, October 2, 2018   (0 Comments - view/add)
Wednesday, September 26, 2018   (0 Comments - view/add)
Brammer Bio announces progress on $200 million program to advance gene therapies »
Brammer Bio announces progress on $200 million program to advance gene therapies   CAMBRIDGE, Mass. , Sept....
Wednesday, September 19, 2018   (0 Comments - view/add)
Bascom Palmer Treats First U.S. Patient in Nightstar Gene Therapy Clinical Trial for X-Linked Retini »
Bascom Palmer Treats First U.S. Patient in Nightstar Gene Therapy Clinical Trial for X-Linked Retinitis Pigmentosa MIA...

Displaying page 1 of 6
1  |  2  |  3  |  4  |  5  |  6

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

NEW regional sponsorship opportunities available.

Connect